FundedIQ
Biotechnology

Forum Markets: Funding, Investors & Team (Oct 2026)

Forum Markets is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University, and Stanford University.

www.ethzilla.com LinkedIn Menlo Park, United States 1-10 employees
Biopharma Biotechnology Health Care Life Science Therapeutics
Total raised
$10.0M
Rounds
1
Latest
Undisclosed round
Mar 2026

Forum Markets has raised $10.0M across 1 funding round on record, the most recent an undisclosed round of $10.0M announced in Mar 2026.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Forum Markets Company Profile and Key Stats

Total funding raised
$10.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$10.0M in Mar 2026
Employees
1-10
reported band
Headquarters
Menlo Park, United States

Latest funding round on record: Mar 2026.

Forum Markets Funding Rounds

Date
Round
Amount
Undisclosed round
$10.0M

Forum Markets Founders and Leadership Team

Name
Role
Contact
Mcandrew Rudisill
Founder
Locked

Contact details for the Forum Markets team: 1 has a LinkedIn profile.

Start 14-day free trial →

Forum Markets Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

Forum Markets' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Forum Markets in Biotechnology and Menlo Park

Companies Similar to Forum Markets

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Forum Markets Funding FAQs

What does Forum Markets do?

Forum Markets is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University, and Stanford University.

How much funding has Forum Markets raised?

Forum Markets has raised $10.0M across 1 round on record. The most recent is an undisclosed round of $10.0M announced in Mar 2026.

When did Forum Markets last raise funding?

Forum Markets' most recent funding round on record is an undisclosed round of $10.0M, announced in Mar 2026.

Who founded Forum Markets?

FundedIQ lists Mcandrew Rudisill (Founder) at Forum Markets.

Where is Forum Markets headquartered?

Forum Markets is based in Menlo Park, California, United States.

How many employees does Forum Markets have?

Forum Markets is in the 1-10 employee band.

How does Forum Markets' funding compare to other Biotechnology startups?

Forum Markets' latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Forum Markets Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Forum Markets is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.